Literature DB >> 16630564

The TTF-1/TAP26 complex differentially modulates surfactant protein-B (SP-B) and -C (SP-C) promoters in lung cells.

Meng-Chun Yang1, Yuhong Guo, Chia-Chi Liu, Jonathan C Weissler, Yih-Sheng Yang.   

Abstract

Surfactant protein-B (SP-B) and -C (SP-C) are small hydrophobic surfactant proteins that maintain surface tension in alveoli. Both SP-B and SP-C are regulated by a key factor, thyroid transcription factor-1 (TTF-1), in lung cells. Previously, we identified a 26-kDa, TTF-1-associated protein (TAP26) that was shown to interact with TTF-1 and enhance TTF-1-transactivated SP-B promoter activity. In this study, we hypothesized that TAP26 could also serve as a co-activator of the SP-C promoter. Using the chromatin immunoprecipitation assay (ChIP), we demonstrated that TAP26 was not only a component of the SP-B promoter, but was also a component of the SP-C promoter complex in lung cells. TAP26 could synergistically stimulate TTF-1-activated SP-B and SP-C promoter activities in H441 cells (a lung adenocarcinoma cell). However, in MLE12 cells (a murine lung type II cell), only SP-B, but not SP-C, promoter activity was improved by TAP26 in a concentration-dependent manner. This result indicated that the TTF-1/TAP26 complex-activated SP-C promoter activity was already optimized in MLE12 cells and that the response of the SP-C promoter to the complex was different from that of the SP-B promoter. Via promoter mutation analysis, adjacent TTF-1 binding sites within the proximal promoter region of SP-C were found to be essential for TTF-1/TAP26-enhanced SP-C promoter activity. Thus, a dimerized complex structure was needed for advanced promoter activity. This result also provided a molecular mechanism by which both the SP-B and SP-C promoters could be differentially regulated by the same complex.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630564     DOI: 10.1016/j.bbrc.2006.03.158

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  The E3 ubiquitin ligase HECW1 targets thyroid transcription factor 1 (TTF1/NKX2.1) for its degradation in the ubiquitin-proteasome system.

Authors:  Jia Liu; Su Dong; Lian Li; Heather Wang; Jing Zhao; Yutong Zhao
Journal:  Cell Signal       Date:  2019-03-05       Impact factor: 4.315

2.  Expression of lung surfactant proteins SP-B and SP-C and their modulating factors in fetal lung of FGR rats.

Authors:  Fei-Tao Deng; Wei-Xiang Ouyang; Liang-Fang Ge; Li Zhang; Xin-Qun Chai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-02-12

3.  PLAGL2 translocation and SP-C promoter activity--a cellular response of lung cells to hypoxia.

Authors:  Yuhong Guo; Meng-Chun Yang; Jonathan C Weissler; Yih-Sheng Yang
Journal:  Biochem Biophys Res Commun       Date:  2007-06-28       Impact factor: 3.575

4.  A Competitive Endogenous RNA Network Based on Differentially Expressed lncRNA in Lipopolysaccharide-Induced Acute Lung Injury in Mice.

Authors:  Xianxian Jia; Jinhui Huang; Bo Wu; Miao Yang; Wei Xu
Journal:  Front Genet       Date:  2021-11-30       Impact factor: 4.599

5.  SMAD3 prevents binding of NKX2.1 and FOXA1 to the SpB promoter through its MH1 and MH2 domains.

Authors:  Parviz Minoo; Lingyan Hu; Nianling Zhu; Zea Borok; Saverio Bellusci; John Groffen; Dimitris Kardassis; Changgong Li
Journal:  Nucleic Acids Res       Date:  2007-11-14       Impact factor: 16.971

6.  SINCERA: A Pipeline for Single-Cell RNA-Seq Profiling Analysis.

Authors:  Minzhe Guo; Hui Wang; S Steven Potter; Jeffrey A Whitsett; Yan Xu
Journal:  PLoS Comput Biol       Date:  2015-11-24       Impact factor: 4.475

7.  Functional roles of C/EBPα and SUMO‑modification in lung development.

Authors:  Yuan-Dong Chen; Jiang-Yan Liu; Yan-Min Lu; Hai-Tao Zhu; Wei Tang; Qiu-Xia Wang; Hong-Yan Lu
Journal:  Int J Mol Med       Date:  2017-08-29       Impact factor: 4.101

8.  Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy.

Authors:  Abul Bashar Mir Md Khademul Islam; Md Abdullah-Al-Kamran Khan
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.